Punctate palmoplantar keratoderma type 1 with a novel AAGAB frameshift mutation: intrafamilial phenotype variation due to ageing
暂无分享,去创建一个
M. Akiyama | T. Takeichi | M. Kono | K. Sugiura | K. Fukai | D. Tsuruta | J. Nagao | N. Shimizu
[1] G. Eckstein,et al. Eight Novel Mutations Confirm the Role of AAGAB in Punctate Palmoplantar Keratoderma Type 1 (Buschke-Fischer-Brauer) and Show Broad Phenotypic Variability. , 2016, Acta dermato-venereologica.
[2] H. Shimizu,et al. Low‐dose etretinate shows promise in management of punctate palmoplantar keratoderma type 1: Case report and review of the published work , 2015, The Journal of dermatology.
[3] H. Sueki,et al. Two Japanese familial cases of punctate palmoplantar keratoderma caused by a novel AAGAB mutation, c.191_194delCAAA. , 2015, Journal of dermatological science.
[4] H. Shimizu,et al. Punctate palmoplantar keratoderma type 1: a novel AAGAB mutation and efficacy of etretinate. , 2015, Acta dermato-venereologica.
[5] T. Strom,et al. Nonsense mutations in AAGAB cause punctate palmoplantar keratoderma type Buschke-Fischer-Brauer. , 2012, American journal of human genetics.
[6] G. Barton,et al. Haploinsufficiency for AAGAB causes clinically heterogeneous forms of punctate palmoplantar keratoderma , 2012, Nature Genetics.